ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Abbott India Names Rehan Khan Managing Director

BANGALORE -(Dow Jones)- Abbott India Ltd. (500488.BY) said Rehan Khan has been appointed as the company's managing director, effective Thursday. Khan is currently general manager and country head of Abbott Nutrition, India, a position he has held since 2009, the Indian unit of Abbott Laboratories (ABT) said in a statement. Khan replaces Vivek Mohan, who has been named senior director, global integrated health, established pharmaceuticals division, at Abbott. Mohan will report to Michael Warmuth, senior vice president, established pharmaceuticals division, at Abbott. -By Rumman Ahmed, Dow Jones Newswires; 91-9845104173; rumman.ahmed@dowjones.com

Stock News for Abbott Labs (ABT)
DateTimeHeadline
04/30/201509:00:00Abbott's First-of-its-Kind Blood Test to Aid in Detecting Early...
04/29/201518:25:19Statement of Changes in Beneficial Ownership (4)
04/29/201518:24:19Statement of Changes in Beneficial Ownership (4)
04/29/201518:23:14Statement of Changes in Beneficial Ownership (4)
04/28/201517:16:21Statement of Changes in Beneficial Ownership (4)
04/28/201517:15:50Statement of Changes in Beneficial Ownership (4)
04/28/201517:15:21Statement of Changes in Beneficial Ownership (4)
04/28/201517:14:50Statement of Changes in Beneficial Ownership (4)
04/28/201517:14:50Statement of Changes in Beneficial Ownership (4)
04/28/201517:13:21Statement of Changes in Beneficial Ownership (4)
04/28/201517:12:21Statement of Changes in Beneficial Ownership (4)
04/28/201517:11:22Statement of Changes in Beneficial Ownership (4)
04/28/201517:10:50Statement of Changes in Beneficial Ownership (4)
04/28/201517:10:20Statement of Changes in Beneficial Ownership (4)
04/27/201520:06:51Makers of Baby Formula Press Their Case on WIC Program
04/27/201517:20:51Current Report Filing (8-k)
04/23/201513:04:14Abbott Laboratories Price Target Raised to $48.00 at JPMorgan...
04/23/201509:37:24Abbott Laboratories's Buy Rating Reaffirmed at Deutsche Bank...
04/23/201509:27:50Abbott Laboratories Stock Rating Reaffirmed by Barclays (ABT)
04/23/201504:30:47Stifel Nicolaus Boosts Abbott Laboratories Price Target to $53.00...

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad